Rating History for Madrigal Pharmaceuticals (MDGL) by Wolfe Research
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 1/6/2026 | Andy Chen | Downgrade | Peerperform (Outperform) |
N/A (N/A) |
588.40 (432.83) |
-26.44% | Details |
 |
|||||||
|
|||||||
|
|||||||
